JP Stock MarketDetailed Quotes

6706 DKK

Watchlist

1643
-34-2.03%

20min DelayMarket Closed Dec 30 15:30 JST

17.91BMarket Cap-8.26P/E (Static)

DKK Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

6.87%5.95B

-9.28%28.86B

-18.54%8.59B

-4.23%7.75B

-11.32%6.96B

4.35%5.57B

-6.33%31.82B

2.06%10.54B

-7.74%8.09B

-4.57%7.85B

Cost of revenue

-0.94%4.84B

-10.96%24.69B

-23.08%7.28B

-3.32%6.51B

-10.88%6.01B

2.20%4.88B

-0.14%27.73B

9.73%9.47B

-3.74%6.74B

2.21%6.75B

Gross profit

62.03%1.12B

2.11%4.17B

21.66%1.3B

-8.66%1.23B

-14.35%943M

22.99%690M

-34.11%4.08B

-37.00%1.07B

-23.63%1.35B

-32.04%1.1B

Operating expense

3.98%1.44B

6.49%5.96B

16.03%1.65B

14.63%1.51B

2.32%1.41B

-6.11%1.38B

-8.95%5.6B

-8.55%1.42B

-16.47%1.32B

-4.96%1.38B

Operating profit

53.82%-320M

-18.33%-1.79B

1.14%-347M

-968.75%-278M

-67.86%-470M

24.01%-693M

-2,950.94%-1.51B

-342.07%-351M

-83.16%32M

-267.66%-280M

Net non-operating interest income (expenses)

-75.00%-7M

-833.33%-22M

-8M

-171.43%-5M

-150.00%-5M

-100.00%-4M

117.65%3M

240.00%7M

60.00%-2M

Non-operating interest income

60.00%8M

-50.00%18M

-55.56%4M

-77.78%4M

0.00%5M

25.00%5M

300.00%36M

200.00%9M

800.00%18M

150.00%5M

Non-operating interest expense

66.67%15M

21.21%40M

33.33%12M

-18.18%9M

42.86%10M

50.00%9M

26.92%33M

50.00%9M

57.14%11M

0.00%7M

Net investment income

-46.02%61M

-49.35%196M

-77.68%52M

0.00%63M

87.60%-32M

-67.62%113M

21.32%387M

94.17%233M

-38.24%63M

-13,000.00%-258M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-100.00%-20M

304.70%1.29B

450.42%1.32B

-15.38%-30M

-75.00%10M

-115.38%-10M

-23.87%319M

-25.47%240M

-140.63%-26M

40M

Income from associates and other participating interests

Special income (charges)

-542.20%-2.1B

-285.02%-1.26B

-327M

Less:Other special charges

----

--76M

----

Less:Write off

----

736.65%2.1B

401.59%1.26B

----

--251M

----

Other non-operating income (expenses)

150.00%25M

284.13%116M

94.34%-15M

1,850.00%78M

-77.95%43M

233.33%10M

-167.74%-63M

-928.13%-265M

-91.67%4M

1,318.75%195M

Income before tax

55.65%-259M

-93.78%-2.31B

45.74%-255M

-1,367.50%-1.01B

-48.52%-453M

-17.98%-584M

-237.25%-1.19B

-176.42%-470M

-79.95%80M

-266.67%-305M

Income tax

85.32%-16M

-525.68%-315M

-157.59%-91M

-36.90%-115M

-78.69%-109M

-71.97%74M

-39.69%158M

-61.64%61M

-423.08%-84M

Net income

48.95%-242M

-57.39%-1.99B

73.77%-165M

-5,436.84%-1.01B

-52.94%-338M

-9.22%-474M

-310.13%-1.27B

-278.19%-629M

-92.05%19M

-240.76%-221M

Net income continuous operations

48.84%-243M

-57.52%-1.99B

73.89%-164M

-5,436.84%-1.01B

-52.94%-338M

-9.45%-475M

-309.62%-1.26B

-277.90%-628M

-92.08%19M

-240.76%-221M

Noncontrolling interests

-500.00%-24M

84.52%-13M

51.72%-28M

300.00%16M

121.43%3M

0.00%-4M

18.45%-84M

-41.46%-58M

85.19%-8M

-216.67%-14M

Net income attributable to the company

53.62%-218M

-67.40%-1.98B

76.22%-136M

-3,778.57%-1.03B

-64.73%-341M

-9.30%-470M

-267.52%-1.18B

-245.55%-572M

-90.48%28M

-243.75%-207M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

53.62%-218M

-67.40%-1.98B

76.22%-136M

-3,778.57%-1.03B

-64.73%-341M

-9.30%-470M

-267.52%-1.18B

-245.55%-572M

-90.48%28M

-243.75%-207M

Gross dividend payment

Basic earnings per share

50.27%-22.78

-84.62%-198.93

71.00%-15.3

-6,200.59%-103.71

-79.53%-34.11

-21.54%-45.81

-281.06%-107.75

-258.58%-52.76

-93.12%1.7

-257.15%-19

Diluted earnings per share

50.27%-22.78

-84.62%-198.93

72.02%-15.3

-6,358.94%-106.4019

-79.98%-34.1957

-21.54%-45.81

-281.06%-107.75

-264.34%-54.6765

-93.12%1.7

-257.60%-19

Dividend per share

0.00%60

0.00%30

0.00%60

-50.00%30

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	6.87%5.95B	-9.28%28.86B	-18.54%8.59B	-4.23%7.75B	-11.32%6.96B	4.35%5.57B	-6.33%31.82B	2.06%10.54B	-7.74%8.09B	-4.57%7.85B
Cost of revenue	-0.94%4.84B	-10.96%24.69B	-23.08%7.28B	-3.32%6.51B	-10.88%6.01B	2.20%4.88B	-0.14%27.73B	9.73%9.47B	-3.74%6.74B	2.21%6.75B
Gross profit	62.03%1.12B	2.11%4.17B	21.66%1.3B	-8.66%1.23B	-14.35%943M	22.99%690M	-34.11%4.08B	-37.00%1.07B	-23.63%1.35B	-32.04%1.1B
Operating expense	3.98%1.44B	6.49%5.96B	16.03%1.65B	14.63%1.51B	2.32%1.41B	-6.11%1.38B	-8.95%5.6B	-8.55%1.42B	-16.47%1.32B	-4.96%1.38B
Operating profit	53.82%-320M	-18.33%-1.79B	1.14%-347M	-968.75%-278M	-67.86%-470M	24.01%-693M	-2,950.94%-1.51B	-342.07%-351M	-83.16%32M	-267.66%-280M
Net non-operating interest income (expenses)	-75.00%-7M	-833.33%-22M	-8M	-171.43%-5M	-150.00%-5M	-100.00%-4M	117.65%3M	0	240.00%7M	60.00%-2M
Non-operating interest income	60.00%8M	-50.00%18M	-55.56%4M	-77.78%4M	0.00%5M	25.00%5M	300.00%36M	200.00%9M	800.00%18M	150.00%5M
Non-operating interest expense	66.67%15M	21.21%40M	33.33%12M	-18.18%9M	42.86%10M	50.00%9M	26.92%33M	50.00%9M	57.14%11M	0.00%7M
Net investment income	-46.02%61M	-49.35%196M	-77.68%52M	0.00%63M	87.60%-32M	-67.62%113M	21.32%387M	94.17%233M	-38.24%63M	-13,000.00%-258M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	-100.00%-20M	304.70%1.29B	450.42%1.32B	-15.38%-30M	-75.00%10M	-115.38%-10M	-23.87%319M	-25.47%240M	-140.63%-26M	40M
Income from associates and other participating interests
Special income (charges)		-542.20%-2.1B	-285.02%-1.26B				-327M	-327M
Less:Other special charges	----	----	----	----	----	----	--76M	----	----	----
Less:Write off	----	736.65%2.1B	401.59%1.26B	----	----	----	--251M	--251M	----	----
Other non-operating income (expenses)	150.00%25M	284.13%116M	94.34%-15M	1,850.00%78M	-77.95%43M	233.33%10M	-167.74%-63M	-928.13%-265M	-91.67%4M	1,318.75%195M
Income before tax	55.65%-259M	-93.78%-2.31B	45.74%-255M	-1,367.50%-1.01B	-48.52%-453M	-17.98%-584M	-237.25%-1.19B	-176.42%-470M	-79.95%80M	-266.67%-305M
Income tax	85.32%-16M	-525.68%-315M	-157.59%-91M	0	-36.90%-115M	-78.69%-109M	-71.97%74M	-39.69%158M	-61.64%61M	-423.08%-84M
Net income	48.95%-242M	-57.39%-1.99B	73.77%-165M	-5,436.84%-1.01B	-52.94%-338M	-9.22%-474M	-310.13%-1.27B	-278.19%-629M	-92.05%19M	-240.76%-221M
Net income continuous operations	48.84%-243M	-57.52%-1.99B	73.89%-164M	-5,436.84%-1.01B	-52.94%-338M	-9.45%-475M	-309.62%-1.26B	-277.90%-628M	-92.08%19M	-240.76%-221M
Noncontrolling interests	-500.00%-24M	84.52%-13M	51.72%-28M	300.00%16M	121.43%3M	0.00%-4M	18.45%-84M	-41.46%-58M	85.19%-8M	-216.67%-14M
Net income attributable to the company	53.62%-218M	-67.40%-1.98B	76.22%-136M	-3,778.57%-1.03B	-64.73%-341M	-9.30%-470M	-267.52%-1.18B	-245.55%-572M	-90.48%28M	-243.75%-207M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	53.62%-218M	-67.40%-1.98B	76.22%-136M	-3,778.57%-1.03B	-64.73%-341M	-9.30%-470M	-267.52%-1.18B	-245.55%-572M	-90.48%28M	-243.75%-207M
Gross dividend payment
Basic earnings per share	50.27%-22.78	-84.62%-198.93	71.00%-15.3	-6,200.59%-103.71	-79.53%-34.11	-21.54%-45.81	-281.06%-107.75	-258.58%-52.76	-93.12%1.7	-257.15%-19
Diluted earnings per share	50.27%-22.78	-84.62%-198.93	72.02%-15.3	-6,358.94%-106.4019	-79.98%-34.1957	-21.54%-45.81	-281.06%-107.75	-264.34%-54.6765	-93.12%1.7	-257.60%-19
Dividend per share	0	0.00%60	0.00%30	0	0.00%30	0	0.00%60	-50.00%30	0	30
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.